Inhibition of C-raf expression by antisense oligonucleotides extends heart allograft survival in rats

Transplantation

Volumn 70, Issue 4, 2000, Pages 656-661

  Stepkowski, Stanislaw M ^a   Qu, Xeimei ^a   Wang, Mou Er ^a   Tian, Ling ^a   Chen, Wenhao ^a   Wancewicz, Edward V ^b   Johnston, Joseph F ^b   Bennett, C Frank ^b   Monia, Brett P ^b  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b ISIS PHARMACEUTICALS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; ESTER DERIVATIVE; MESSENGER RNA; NUCLEOTIDE; PHOSPHOROTHIOIC ACID; PROTEIN SERINE THREONINE KINASE; RAPAMYCIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; ENZYME INHIBITION; GRAFT SURVIVAL; HEART TRANSPLANTATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN MODIFICATION; RAT; SIGNAL TRANSDUCTION; SURVIVAL RATE; T LYMPHOCYTE;

EID: 0034721317     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-200008270-00020     Document Type: Article

References (30)

1. The T cell antigen receptor: Insights into organelle bioloby
2. T cell antigen receptor signal transduction: A tale of tails and cytoplasmic protein-tyrosine kinases
3. Protein serine/threonine kinases of the MAPK cascade
4. Differential signaling by limphocytes antigen receptors
5. The role of the CD28 receptor during T cell responses to antigen
6. RelA is a potent transcriptional activator of the CD28 response element within the interleukin-2 promotor
7. Cytokine receptor signaling
8. Transcriptional responses to polypeptide ligands: The JAK-STAT
9. JAKs and STATs. biological implications
10. The ins and outs of Raf kinases
11. The T cell antigen receptor utilizes Lck, Raf-1, and MEK-1 for activating mitogen-activated protein kinase. Evidence for the existence of a second progein kinase C-dependent pathway in an Lck-negative Jurkat cell mutant
12. Diversity in functin and regulation of MAP kinase pathways
13. Selective inhibition of A-raf and C-raf mRNA expression by antisense oligodeoxynucelotides in rat vascular smooth muscle cells: Role of A-raf and C-raf in serum-induced proliferation
14. Antitumor activity of a phosphorothioate antisense oligodeoxynucleotide targeted against C-raf kinase
15. Blocking of heart allograft rejection by intercellular adhesion molecule-1 antisense oligonucleotides alone or in combination with other immunosuppressive modalities
16. Toxicological and pharmacokinetic properties of chemically modified antisense oligonucleotide inhibitors of PKC- and C-raf kinase
17. Improved technique of heart transplantation in rats
18. The median effect principle and the combination index for quantitation of synergism and antagonism
19. IFN-production from human Th1 cells is controlled by Raf kinase
20. The mitogenic response of T cells to interleukin-2 requires Raf-1
21. The effect of C-raf antisense oligonucleotides on growth factor-induced proliferation of hematopoietic cells
22. A role for c-Raf kinase and Ha-Ras in cytokine-mediated induction of cell adhesion molecules
23. Second generation of antisense oligonucleotides: From nuclease resistance to biological efficacy in animals
24. Substrate specificity and kinetics of degradation of antisense oligonucleotides by a 3' exonu-clease in plasma
25. Cyclosporin A in patients receiving renal allografts from cadaver donors
26. Effects of the pharmacokinetic interaction between orally administered sirolimus and cyclosporine on the synergistic prolongation of heart allograft survival in rats
27. Immunosuppressive effects and safety of a sirolimus/cyclosporine combination regimen for renal transplantation
28. The side effect profile of sirolimus: A phase I study in quiescent cyclosporine-prednisone-treated renal transplant patients
29. Protection against allograft rejection with intercellular adhesion molecule-1 antisense oligodeoxynucleotides
30. Toxicity of oligodeoxynucleotide therapeutic agents